effective compared with uterine artery embolisation, myomectomy and hysterectomy
Evidence comparing MRgFUS with other uterine-preserving treatments is limited to two non-randomised studies suggesting that UAE results in better outcomes. Evidence on the safety of MRgFUS from uncontrolled observational studies suggests that major complications are rare. The effects of the procedure on fertility and future pregnancy are uncertain. Overall, the evidence is inconsistent and inconclusive surrounding the cost effectiveness of MRgFUS 
Evidence note 57. Is patient self-monitoring (including self-testing and selfmanagement) of oral anticoagulation therapy safe, efficacious and cost-effective?
Meta-analyses of mainly low quality RCTs in patients receiving long-term oral anticoagulation therapy with vitamin K antagonists report that self-management of INR reduces the incidence of thromboembolic events, compared with usual care, without increasing major bleeding events. The benefit is not seen with self-testing. It is likely that self-monitoring is a safe option for competent and motivated patients. See also Advice Statement 003/15 http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicin es/shtg_advice_statements/advice_statement_003-15.aspx HIS Evidence Note Systematic search: Limited December 2015 http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicin es/shtg_-_evidence_notes/evidence_note_57.aspx
HTA 13 Antimicrobial wound dressings (AWDs) for chronic wounds
The published evidence base on the clinical effectiveness of antimicrobial wound dressings was found to be of insufficient quality to support or refute their use. SIGN and SHTG researchers recruited NHS Scotland staff to participate in a modified Delphi process resulting in a series of eight statements to guide practice. HIS Health Technology Assessment Systematic search: Yes December 2015 http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicin es/shtg_-_hta/hta13_antimicrobial_dressings.aspx
SGHD

Nil
SIGN
Next guidelines due "Spring 2016"
HEALTH SCOTLAND
Nil
NICE
NICE MTA 374 Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy
Erlotinib is recommended as an option for treating locally advanced or metastatic non-small-cell lung cancer that has progressed in people who have had non-targeted chemotherapy because of delayed confirmation that their tumour is epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation-positive NICE Multiple Technology Assessment 
NG31 Care of dying adults in the last days of life
This guideline covers the clinical care of adults who are dying during the last 2 to 3 days of life. It aims to improve end of life care for people in their last days of life by communicating respectfully and involving them, and the people important to them, in decisions and by maintaining their comfort and dignity. The guideline covers how to manage common symptoms without causing unacceptable side effects and maintain hydration in the last days of life. NICE Guidance Systematic search: Yes December 2015 https://www.nice.org.uk/guidance/ng31 NG30 Oral health promotion: general dental practice This guideline covers how general dental practice teams can convey advice about oral hygiene and the use of fluoride. It also covers diet, smoking, smokeless tobacco and alcohol intake. The recommendations cover oral health advice given by dentists and dental care professionals, and how dentists and dental care professionals can adopt a patient-centred approach NICE Guidance Systematic search: Yes December 2015 https://www.nice.org.uk/guidance/ng30
NG29 Intravenous fluid therapy in children and young people in hospital
This guideline covers general principles for managing intravenous (IV) fluids for children and young people under 16 years, including assessing fluid and electrolyte status and prescribing IV fluid therapy. It applies to a range of conditions and different settings. It does not include recommendations relating to specific conditions. NICE Guidance Systematic search: Yes December 2015 https://www.nice.org.uk/guidance/ng29
NG27 Transition between inpatient hospital settings and community or care home settings for adults with social care needs
This guideline covers the transition between inpatient hospital settings and community or care homes for adults with social care needs. It aims to improve people's experience of admission to, and discharge from, hospital by better coordination of health and social care services. 
Management of Insomnia Disorder
Low to moderate strength evidence supported several interventions for insomnia disorder. This review supports the efficacy of cognitive behavioral therapy for insomnia (CBT-I) in both the general adult population and the older adult population. Other psychological interventions did not have sufficient evidence of efficacy. In older adults, multicomponent behavioral therapy as well as CBT-I has evidence of efficacy across several sleep outcomes. Evidence shows the efficacy of nonbenzodiazapine hypnotics for treating insomnia disorder across several outcomes among the general adult population and older adults. Overall, several options exist to treat insomnia disorder in adults and older adults. Psychological approaches may be more sustainable and are less likely to harm. AHRQ Research Synthesis Systematic Search: Yes December 2015 http://www.effectivehealthcare.ahrq.gov/ehc/products/548/2164/Insomnia-executive-151230.pdf
Diagnosis of Right Lower Quadrant Pain and Suspected Acute Appendicitis
Studies assessing multiple tests are typically not designed to provide comparative information so while there is fairly strong evidence about the performance of individual tests, there is little about comparative effectiveness. Clinical symptoms and signs and laboratory tests have relatively limited test performance when used in isolation. All three major imaging modalities (US, CT, & MRI) have adequate test performance. AHRQ Research Synthesis Systematic Search: Yes December 2015 http://www.effectivehealthcare.ahrq.gov/ehc/products/528/2159/appendicitisexecutive-151214.pdf
